No evidence in US of HPV16/18 cancer precursor reduction.
Pendleton, M Eli; Ruffin, Mack T; Harper, Diane M.
; 34(2): 200, 2016 Jan 04.
Artigo em Inglês | MEDLINE | ID: mdl-26232544
Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008-2015.
Monitoring the impact of a national HPV vaccination program in Japan (MINT Study): rationale, design and methods.
A 12-Year Follow-up on the Long-Term Effectiveness of the Quadrivalent Human Papillomavirus Vaccine in 4 Nordic Countries.
Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States - 2008-2012.
Response to Pendleton et al. regarding reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States.
Declines in Human Papillomavirus (HPV)-Associated High-Grade Cervical Lesions After Introduction of HPV Vaccines in Connecticut, United States, 2008-2015.
Dietary methionine restriction inhibits prostatic intraepithelial neoplasia in TRAMP mice.
Recent increase in incidence of cervical precancerous lesions in Norway: Nationwide study from 1992 to 2016.
Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting.
Trends in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers, 2008-2014.